Ken Griffin’s Top 5 Stock Holdings Revealed: Where the Billionaire Is Betting Big in 2025

Wall Street's whale just showed his cards—and the hand is predictably massive.

Griffin's equity empire spans everything from tech titans to defensive plays, with positions so large they could move markets on a bad day. The Citadel founder isn't just investing—he's building fortresses.

Tech dominance leads the charge. No surprise here—big money follows big innovation. The positions read like a who's-who of corporate America, each holding carefully calibrated to balance growth with stability.

One eyebrow-raising allocation? A seemingly boring play that actually screams 'recession hedge.' Because even billionaires get nervous sometimes—they just hedge better than the rest of us.

Energy makes a surprise appearance. Not the flashy renewables everyone talks about—old-school, cash-gushing energy that funds those yacht parties and political donations.

The bottom line: Griffin's portfolio looks less like a stock pick and more like a corporate takeover list. Because when you have billions, you don't buy shares—you buy influence. And apparently, you still overpay for the same stocks everyone else owns—just with more zeros at the end.

Image source: Getty Images.

Here are Citadel's top five stock holdings, as of its second-quarter 13F filing, excluding options such as puts and calls. Each represents less than 1% of the Citadel portfolio.

• Nvidia (NVDA -0.05%): The semiconductor company has been a market darling in recent years, thanks to its extraordinary success in the artificial intelligence processor market. In Q2, Citadel bought 6.5 million more shares of the stock, reflecting confidence in it.
• Hess: Hess was acquired by Chevron in July (after Q2 ended) in an all-stock deal. But Chevron also seems like a fine stock to own due to the oil and natural gas company's robust cash flow, growth prospects, and its solid dividend, which at recent prices yielded 4.4%.
• Amazon.com (AMZN 0.15%): Few people will scratch their heads at someone owning shares of this e-commerce and cloud computing giant, which has lots of room to grow. Citadel added 3.3 million shares to its position last quarter, more than doubling its stake in the company.
• Edwards Lifesciences (EW -0.71%): Edwards Lifesciences is less well-known. It was spun off from Baxter International in 2000 and is focused on medical devices, particularly for the heart. Citadel recently owned about 2% of the company, but shed nearly 5% of its position in it last quarter.
• JPMorgan Chase (JPM 1.35%): This financial services titan is another solid dividend payer, and the stock yields 1.9%. Some see the stock as slightly overvalued, but Citadel added to its stake in the last quarter.

Just because a hedge fund owns these stocks doesn't mean you should buy them -- unless, after you dig deeper into them, you are confident in their futures. After all, every investor and hedge fund has their own time horizon, risk tolerance, and goals.